Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in women at high-bleeding risk: Insights from the POEM trial.
Maurina M, Pivato CA, Kunadian V, Testa L, Briguori C, Pacchioni A, Latini AC, Cesani N, Piccolo R, Musto C, Sardella G, Indolfi C, Regazzoli D, Paradies V, Stefanini G. Maurina M, et al. Among authors: indolfi c. Catheter Cardiovasc Interv. 2024 Nov;104(6):1129-1138. doi: 10.1002/ccd.31255. Epub 2024 Oct 3. Catheter Cardiovasc Interv. 2024. PMID: 39359172
Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation.
Giordano A, Corcione N, Ferraro P, Morello A, Conte S, Testa L, Bedogni F, Iadanza A, Berti S, Regazzoli D, Romagnoli E, Trani C, Burzotta F, Pepe M, Frati G, Biondi-Zoccai G; Registro Italiano GISE sull’impianto di Valvola Aortica Percutanea (RISPEVA) Study Investigators. Giordano A, et al. Sci Rep. 2019 Nov 19;9(1):17098. doi: 10.1038/s41598-019-53081-w. Sci Rep. 2019. PMID: 31745198 Free PMC article.
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial.
Popolo Rubbio A, Testa L, Pivato CA, Regazzoli D, Piccolo R, Esposito G, Musto C, Scalia L, Pacchioni A, Briguori C, Lucisano L, De Luca L, Conrotto F, Tartaglia F, Latini AC, Stankowski K, Chiarito M, Sardella G, Indolfi C, Bedogni F, Reimers B, Condorelli G, Stefanini GG. Popolo Rubbio A, et al. Among authors: indolfi c. Cardiovasc Revasc Med. 2024 Oct;67:77-83. doi: 10.1016/j.carrev.2024.04.022. Epub 2024 Apr 16. Cardiovasc Revasc Med. 2024. PMID: 38702260 Clinical Trial.
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry.
Onorati F, D'Errigo P, Barbanti M, Rosato S, Covello RD, Maraschini A, Ranucci M, Santoro G, Tamburino C, Grossi C, Santini F, Menicanti L, Seccareccia F; OBSERVANT Research Group. Onorati F, et al. J Thorac Cardiovasc Surg. 2014 May;147(5):1529-39. doi: 10.1016/j.jtcvs.2013.05.039. Epub 2013 Jul 13. J Thorac Cardiovasc Surg. 2014. PMID: 23856202 Free article.
Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes.
Belmonte M, Foà A, Paolisso P, Bergamaschi L, Gallinoro E, Polimeni A, Scarsini R, Muscoli S, Amicone S, De Vita A, Villano A, Angeli F, Armillotta M, Sucato V, Tremamunno S, Morrone D, Indolfi C, Filardi PP, Ribichini F, Lanza GA, Chieffo A, Barbato E, Pizzi C; Coronary Physiopathology and Microcirculation Working Group of the Italian Society of Cardiology (SIC). Belmonte M, et al. Among authors: indolfi c. Prog Cardiovasc Dis. 2024 Oct 22:S0033-0620(24)00142-7. doi: 10.1016/j.pcad.2024.10.006. Online ahead of print. Prog Cardiovasc Dis. 2024. PMID: 39447854 Review.
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease. Study design and rationale of the EXECUTIVE trial.
Ribichini F, Ansalone G, Bartorelli A, Beqaraj F, Berni A, Colangelo S, D'Amico M, Della Rovere F, Fiscella A, Gabrielli G, Indolfi C, La Vecchia L, Loschiavo P, Marinoni G, Marzocchi A, Milazzo D, Romano M, Sangiorgio P, Sheiban I, Tamburino C, Tuccillo B, Villani R, Cappi B, Quijada MJ, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. Among authors: indolfi c. J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):299-309. doi: 10.2459/JCM.0b013e3283331e69. J Cardiovasc Med (Hagerstown). 2010. PMID: 20090550 Clinical Trial.
[SIC Position paper: Treat to prevent the first event - intensive LDL cholesterol lowering in patients at very high cardiovascular risk without a previous cardiovascular event. From ESC guidelines to clinical practice].
Perrone Filardi P, Nardi E, Agostoni P, Barillà F, Calabrò P, Ciccone MM, Curcio A, Indolfi C, Muscoli S, Nodari S, Paolillo S, Patti G, Porto I, Sinagra G, Gallo L, Fontanarosa S, Vizza CD, Gargiulo P. Perrone Filardi P, et al. Among authors: indolfi c. G Ital Cardiol (Rome). 2024 Jul;25(7):530-540. doi: 10.1714/4282.42641. G Ital Cardiol (Rome). 2024. PMID: 38916469 Italian.
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)].
Porcari A, Chimenti C, Merlo M, Musca F, Vergaro G, Iacoviello M, Aimo A, Di Lenarda A, Canepa M, Cappelli F, Cipriani A, Di Bella G, Forleo C, Imazio M, Limongelli G, Longhi S, Musumeci B, Obici L, Perfetto F, Perlini S, Serenelli M, Tomasoni D, Vagnarelli F, Merlini G, Palladini G, Metra M, Colivicchi F, Indolfi C, Grimaldi M, Perrone Filardi P, Emdin M, Sinagra G, Oliva F. Porcari A, et al. Among authors: indolfi c. G Ital Cardiol (Rome). 2024 Dec;25(12):900-920. doi: 10.1714/4372.43703. G Ital Cardiol (Rome). 2024. PMID: 39588628 Italian.
542 results